Excelsior Medical Co., Ltd.
Research Excelsior Medical Co., Ltd. (4104.TW) on Bullrun: market cap TWD 13.92B, P/E 15.0, dividend yield 6.0%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker4104.TW
- ExchangeTW
- CountryTaiwan
- SectorHealthcare
- IndustryMedical Distribution
- CurrencyTWD
- Market capTWD 13.92B
- P/E15.0
- Dividend yield6.0%
- Financial periodQ2 2026
- RevenueTWD 2.39B
- Net incomeTWD 308.50M
- Free cash flowTWD 289.27M
- Gross margin21.7%
Valuation Snapshot
latest market cap is TWD 13.92B; P/E is 15.0; dividend yield is 6.0%.
Peer valuation comparison
Latest P/E is 15.02x versus a Healthcare sector median of 21.8x (31.1% below).
Latest dividend yield is 5.97% versus a Healthcare sector median of 2.4% (148.8% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | TWD 13.92B | 15.0 | 5.8% | 4.3 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 4.3 TWD, yield 6.0%.
About Excelsior Medical Co., Ltd.
Excelsior Medical Co., Ltd., together with its subsidiaries, engages in the sale of medical supplies and equipment, medicines, and home medical devices in Taiwan, Hong Kong, China, the Philippines, Malaysia, and Indonesia. It operates through Excelsior, Dynamic, Arich, and Other segments. The company offers hemodialysis/plasma exchange; blood bags; artificial stomas; and health appliances. It is also involved in the sale, maintenance, and lease of laser medical equipment for beauty treatment;
ETFs that hold Excelsior Medical Co., Ltd.
US-listed ETFs
Excelsior Medical Co., Ltd. is held by 12 US-listed ETFs, going by the latest portfolios they filed with the SEC. The 8 most traded of them:
| ETF | Weight | Fee |
|---|---|---|
| Avantis Emerging Markets Equity ETF (AVEM) | <0.01% | 0.33% |
| State Street SPDR Portfolio Emerging Markets ETF (SPEM) | <0.01% | 0.07% |
| Dimensional Emerging Core Equity Market ETF (DFAE) | <0.01% | 0.29% |
| Dimensional Emerging Markets Core Equity 2 ETF (DFEM) | <0.01% | 0.39% |
| Dimensional World ex U.S. Core Equity 2 ETF (DFAX) | <0.01% | 0.28% |
| Dimensional Emerging Markets Value ETF (DFEV) | 0.01% | 0.43% |
| Avantis Emerging Markets Value ETF (AVES) | <0.01% | 0.36% |
| State Street SPDR S&P Emerging Markets Small Cap ETF (EWX) | 0.02% | 0.65% |
Portfolios as filed with the SEC on Form N-PORT, dated May to July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Excelsior Medical Co., Ltd.'s market cap?
Excelsior Medical Co., Ltd.'s market capitalization is TWD 13.92B.
What is Excelsior Medical Co., Ltd.'s P/E ratio?
Excelsior Medical Co., Ltd.'s price-to-earnings (P/E) ratio is 15.0.
Does Excelsior Medical Co., Ltd. pay a dividend?
Excelsior Medical Co., Ltd. has a dividend yield of 6.0%.
What does Excelsior Medical Co., Ltd. do?
Excelsior Medical Co., Ltd., together with its subsidiaries, engages in the sale of medical supplies and equipment, medicines, and home medical devices in Taiwan, Hong Kong, China, the Philippines, Malaysia, and Indonesia. It operates through Excelsior, Dynamic, Arich, and Other segments. The company offers hemodialysis/plasma exchange; blood bags; artificial stomas; and health appliances.